UA88322C2 - Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder - Google Patents

Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder

Info

Publication number
UA88322C2
UA88322C2 UAA200703875A UAA200703875A UA88322C2 UA 88322 C2 UA88322 C2 UA 88322C2 UA A200703875 A UAA200703875 A UA A200703875A UA A200703875 A UAA200703875 A UA A200703875A UA 88322 C2 UA88322 C2 UA 88322C2
Authority
UA
Ukraine
Prior art keywords
agomelatine
medicaments
treatment
production
anxiety disorder
Prior art date
Application number
UAA200703875A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Брюно Делальо
Анье Фабиано
Марк Миллан
Элизабет Мокер
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Priority to UAA200703875A priority Critical patent/UA88322C2/en
Publication of UA88322C2 publication Critical patent/UA88322C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the use of agomelatine or N-[2-(7-methoxy-l-naphthyl)ethyl]acetamide for the production of medicaments for use in the treatment of generalized anxiety disorder.
UAA200703875A 2007-04-06 2007-04-06 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder UA88322C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA200703875A UA88322C2 (en) 2007-04-06 2007-04-06 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200703875A UA88322C2 (en) 2007-04-06 2007-04-06 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder

Publications (1)

Publication Number Publication Date
UA88322C2 true UA88322C2 (en) 2009-10-12

Family

ID=50636327

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200703875A UA88322C2 (en) 2007-04-06 2007-04-06 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder

Country Status (1)

Country Link
UA (1) UA88322C2 (en)

Similar Documents

Publication Publication Date Title
JO3440B1 (en) Use of Agomelatine in Obtaining Medicaments Intended For The Treatment of Generalized Anxiety Disorder
MX2010007490A (en) Preparation of sulfamide derivatives.
HK1170429A1 (en) Alpha aminoamide derivatives useful in the treatment of cognitive disorders
MY161656A (en) Therapeutic use of diaminophenothiazines
EA200601449A1 (en) APPLICATION OF AGOMELATIN TO OBTAIN MEDICINAL AGENTS INTENDED FOR THE TREATMENT OF SLEEP DISORDERS IN A PATIENT WITH DEPRESSION
CL2011002231A1 (en) Crystal form vi of agomelatine; Preparation process; pharmaceutical composition; and its use to treat stress, anxiety, sleep disorders, cardiovascular diseases, schizophrenia, phobia, depression, diseases of the digestive system.
MX2010010597A (en) Processes for the preparation of benzo-fused dioxin derivatives.
MX2013002121A (en) Substituted quinoline-3-carboxamides as kcnq2/3 modulators.
GEP20156225B (en) Therapeutic agent for anxiety disorders
MY145139A (en) Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome
EA201201123A1 (en) APPLICATION OF AGOMELATIN TO OBTAIN MEDICINAL AGENTS INTENDED FOR THE TREATMENT OF OBJECTIVE-COMPULSIVE DISORDERS (OCD)
TNSN07364A1 (en) Use of agomelatine for obtaining medicaments used for treating bipolar disorders
UA88322C2 (en) Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder
SG143202A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia
CU20070070A7 (en) PHARMACEUTICAL COMPOSITION OF AGOMELATIN
UA100552C2 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety and related disorders
MD20160072A2 (en) Novel method for the synthesis of 7-methoxy-naphthalene-1-carbaldehyde and use thereof in the synthesis of agomelatine
CU20070232A7 (en) USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF BIPOLAR DISORDERS
MX2015006807A (en) METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)- N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXA MIDE AND CRISTAL FORMS THEREOF.
CR20130300A (en) NEW AGOMELATINE SYNTHESIS PROCEDURE